Topic of the Month on ModernWeight: GLP-1 Success Stories!
Head to the Social Hub to share your success story or learn about others.
AOMs in the News
This Week's Featured Post
Weighing the Social Costs of Weight-Loss Drugs
Link: MedicalXPress
With the surge in popularity of GLP-1 weight-loss medications like Ozempic and Wegovy, many people are flocking to these drugs for quick results. However, a deeper conversation is emerging around the broader implications of relying on medication to combat obesity. This week’s featured post dives into a thought-provoking Q&A with experts discussing the societal impact of GLP-1s, questioning whether these medications truly address the root causes of obesity or if they merely mask larger social issues.
The Q&A highlights key questions, such as whether weight-loss drugs contribute to reinforcing societal pressures around thinness and beauty standards, and if they might detract from necessary public health interventions like promoting healthier food environments. Experts also discuss concerns around access and equity, noting that these medications may be more accessible to affluent individuals, potentially widening health disparities. The discussion also touches on the sustainability of using GLP-1s long-term and the potential psychological impacts of relying on medication for weight management.
Why it Matters: While these medications are effective, they may overshadow the critical need for broader societal changes to combat obesity. Experts argue that the focus on medication may lead to neglecting important discussions about the social and environmental factors contributing to obesity. As the demand for GLP-1s continues to grow, it’s vital to consider who is getting access to these drugs and the long-term implications for public health.
Mounjaro, Zepbound: Tirzepatide Reduces Diabetes Risk by 94%
Link: Healthline
A recent clinical trial revealed that the GLP-1 drug tirzepatide, sold under the brand names Mounjaro and Zepbound, reduced the risk of progression from prediabetes to type 2 diabetes by 94%. This study, conducted over three years, also demonstrated significant weight loss among participants. However, those who discontinued the medication began to regain weight and saw a decline in their risk reduction for diabetes.
Why it Matters: This study highlights the long-term benefits of GLP-1 drugs like tirzepatide for weight loss and diabetes prevention. However, it also underscores the importance of ongoing treatment and lifestyle changes to maintain these health gains.
Researchers Claim Weight-Loss Drugs Are Altering Metabolism
Link: Dallas Express
New research suggests that GLP-1 drugs like Ozempic, Wegovy, and Mounjaro don't just reduce appetite but may also alter metabolism. The study found that people who took GLP-1 medications for 24 weeks experienced both weight loss and an increased metabolic rate. This finding challenges the previous understanding that these drugs only work by making people feel fuller.
Why it Matters: If GLP-1 drugs can indeed alter metabolism, it could lead to a deeper understanding of how these medications work and potentially open up new avenues for treating obesity and metabolic disorders.
Opportunities to Optimize Lifestyle Interventions with GLP-1s
This article explores the potential to enhance lifestyle interventions, such as diet and exercise, when used alongside GLP-1 medications. The authors emphasize that combining these interventions with GLP-1 therapy can lead to better health outcomes than either approach alone.
Why it Matters: Optimizing the use of GLP-1 medications with lifestyle interventions can help patients achieve more sustainable weight loss and improved overall health, underscoring the importance of a comprehensive approach to obesity treatment.
Better Utilization Management Needed for GLP-1 Agonists
Experts from Kaiser Permanente stress the need for better utilization management of GLP-1 agonists, particularly in light of their high cost and the growing demand driven by social media. They argue that many patients could achieve similar results through lifestyle modifications or less expensive medications like phentermine. The article also highlights the importance of ensuring that GLP-1 agonists are used appropriately, with a focus on long-term effectiveness and patient safety.
Why it Matters: With the rising popularity of GLP-1 drugs, it's crucial to ensure that they are used effectively and appropriately. Better utilization management can help control costs, reduce side effects, and ensure that patients receive the most appropriate treatment for their needs.
Expert Tweet of the Week
From @BevTchangMD
"Happy to see that #research is getting better at capturing the full benefits of #obesity treatment:"
Related Article: Wiley Research Article
---
Our ModernWeight "Weekly Weight Management Insights" newsletter is designed to keep you informed and engaged with the latest in weight management and GLP-1 medications. Visit the Social Hub to join the conversation and connect with our community.
Want to receive this newsletter in your inbox weekly? Create a profile!
Comments